These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31403949)

  • 1. Clinical and Pathological Benefits of Edaravone for Alzheimer's Disease with Chronic Cerebral Hypoperfusion in a Novel Mouse Model.
    Feng T; Yamashita T; Shang J; Shi X; Nakano Y; Morihara R; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Matsumoto N; Hishikawa N; Ohta Y; Abe K
    J Alzheimers Dis; 2019; 71(1):327-339. PubMed ID: 31403949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of edaravone on white matter pathology in a novel mouse model of Alzheimer's disease with chronic cerebral hypoperfusion.
    Feng T; Yamashita T; Sasaki R; Tadokoro K; Matsumoto N; Hishikawa N; Abe K
    J Cereb Blood Flow Metab; 2021 Jun; 41(6):1437-1448. PubMed ID: 33106078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.
    Shang J; Yamashita T; Tian F; Li X; Liu X; Shi X; Nakano Y; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    Brain Res; 2019 Nov; 1723():146379. PubMed ID: 31415766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits.
    Jiao SS; Yao XQ; Liu YH; Wang QH; Zeng F; Lu JJ; Liu J; Zhu C; Shen LL; Liu CH; Wang YR; Zeng GH; Parikh A; Chen J; Liang CR; Xiang Y; Bu XL; Deng J; Li J; Xu J; Zeng YQ; Xu X; Xu HW; Zhong JH; Zhou HD; Zhou XF; Wang YJ
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5225-30. PubMed ID: 25847999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Pathological Benefits of Scallop-Derived Plasmalogen in a Novel Mouse Model of Alzheimer's Disease with Chronic Cerebral Hypoperfusion.
    Feng T; Hu X; Fukui Y; Bian Z; Bian Y; Sun H; Takemoto M; Yunoki T; Nakano Y; Morihara R; Abe K; Yamashita T
    J Alzheimers Dis; 2022; 86(4):1973-1982. PubMed ID: 35253748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer's disease model.
    Parikh A; Kathawala K; Li J; Chen C; Shan Z; Cao X; Wang YJ; Garg S; Zhou XF
    Drug Des Devel Ther; 2018; 12():2111-2128. PubMed ID: 30022810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Pathological Benefit of Twendee X in Alzheimer's Disease Transgenic Mice with Chronic Cerebral Hypoperfusion.
    Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1993-2002. PubMed ID: 31029568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia.
    Kelliny S; Xiong J; Bobrovskaya L; Zhou XF
    Neurotox Res; 2021 Dec; 39(6):1689-1707. PubMed ID: 34599751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceleration of NLRP3 inflammasome by chronic cerebral hypoperfusion in Alzheimer's disease model mouse.
    Shang J; Yamashita T; Zhai Y; Nakano Y; Morihara R; Li X; Tian F; Liu X; Huang Y; Shi X; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    Neurosci Res; 2019 Jun; 143():61-70. PubMed ID: 29885344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic cerebral hypoperfusion induces memory deficits and facilitates Aβ generation in C57BL/6J mice.
    Wang L; Du Y; Wang K; Xu G; Luo S; He G
    Exp Neurol; 2016 Sep; 283(Pt A):353-64. PubMed ID: 27421879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Effects of Rivaroxaban on White Matter Integrity and Remyelination in a Mouse Model of Alzheimer's Disease Combined with Cerebral Hypoperfusion.
    Bian Z; Hu X; Liu X; Yu H; Bian Y; Sun H; Fukui Y; Morihara R; Ishiura H; Yamashita T
    J Alzheimers Dis; 2023; 96(2):609-622. PubMed ID: 37840489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twendee X Ameliorates Phosphorylated Tau, α-Synuclein and Neurovascular Dysfunction in Alzheimer's Disease Transgenic Mice With Chronic Cerebral Hypoperfusion.
    Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104310. PubMed ID: 31383622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer's Disease Model Mouse.
    Shang J; Yamashita T; Zhai Y; Nakano Y; Morihara R; Fukui Y; Hishikawa N; Ohta Y; Abe K
    J Alzheimers Dis; 2016 Mar; 52(1):113-26. PubMed ID: 27060955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edaravone attenuates oxidative stress induced by chronic cerebral hypoperfusion injury: role of ERK/Nrf2/HO-1 signaling pathway.
    Zhang D; Xiao Y; Lv P; Teng Z; Dong Y; Qi Q; Liu Z
    Neurol Res; 2018 Jan; 40(1):1-10. PubMed ID: 29125058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Edaravone injection reverses learning and memory deficits in a rat model of vascular dementia.
    Li X; Lu F; Li W; Qin L; Yao Y; Ge X; Yu Q; Liang X; Zhao D; Li X; Zhang J
    Acta Biochim Biophys Sin (Shanghai); 2017 Jan; 49(1):83-89. PubMed ID: 27864280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic cerebral hypoperfusion accelerates Alzheimer's disease pathology with the change of mitochondrial fission and fusion proteins expression in a novel mouse model.
    Feng T; Yamashita T; Zhai Y; Shang J; Nakano Y; Morihara R; Fukui Y; Hishikawa N; Ohta Y; Abe K
    Brain Res; 2018 Oct; 1696():63-70. PubMed ID: 29879414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Edaravone Attenuates Aβ 1-42-Induced Inflammatory Damage and Ferroptosis in HT22 Cells.
    Guo S; Lei Q; Guo H; Yang Q; Xue Y; Chen R
    Neurochem Res; 2023 Feb; 48(2):570-578. PubMed ID: 36333599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration.
    Zhao Y; Gong CX
    Cell Mol Neurobiol; 2015 Jan; 35(1):101-10. PubMed ID: 25352419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.